Measurable Residual Disease in Hematological Cancers

Cancers (Basel). 2024 Nov 5;16(22):3722. doi: 10.3390/cancers16223722.

Abstract

Minimal residual disease (MRD) is most easily defined as a minimal amount of cancer cells that remain following the treatment of the disease, potentially owing to disease recurrence and the patient's dismal prognosis [...].

Publication types

  • Editorial

Grants and funding

This research received no external funding.